Christine T Mui

Array ( [id] => 5642634 [patent_doc_number] => 20060281089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Methods for detecting cancer and monitoring cancer progression' [patent_app_type] => utility [patent_app_number] => 10/559232 [patent_app_country] => US [patent_app_date] => 2004-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11156 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20060281089.pdf [firstpage_image] =>[orig_patent_app_number] => 10559232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 463124 [patent_doc_number] => 07238524 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-03 [patent_title] => 'Prostate cancer cell lines' [patent_app_type] => utility [patent_app_number] => 10/862256 [patent_app_country] => US [patent_app_date] => 2004-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 19 [patent_no_of_words] => 5411 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/238/07238524.pdf [firstpage_image] =>[orig_patent_app_number] => 10862256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8257833 [patent_doc_number] => 08207311 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-26 [patent_title] => 'Ovr115 antibody compositions and methods of use' [patent_app_type] => utility [patent_app_number] => 10/556478 [patent_app_country] => US [patent_app_date] => 2004-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 38 [patent_no_of_words] => 50598 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10556478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5177041 [patent_doc_number] => 20070178101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-02 [patent_title] => 'Ovr110 antibody compositions and methods of use' [patent_app_type] => utility [patent_app_number] => 10/557331 [patent_app_country] => US [patent_app_date] => 2004-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 45883 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20070178101.pdf [firstpage_image] =>[orig_patent_app_number] => 10557331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5182548 [patent_doc_number] => 20070053894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => 'Compound and method for regulating plasminogen activation and cell migration' [patent_app_type] => utility [patent_app_number] => 10/556145 [patent_app_country] => US [patent_app_date] => 2004-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 18308 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20070053894.pdf [firstpage_image] =>[orig_patent_app_number] => 10556145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 270363 [patent_doc_number] => 07563599 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-21 [patent_title] => 'Reshaped human antibody to human medulloblastoma cells' [patent_app_type] => utility [patent_app_number] => 10/839799 [patent_app_country] => US [patent_app_date] => 2004-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13640 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/563/07563599.pdf [firstpage_image] =>[orig_patent_app_number] => 10839799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5887745 [patent_doc_number] => 20060275330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Pygopus in diagnosis and treatment of cancer' [patent_app_type] => utility [patent_app_number] => 10/553661 [patent_app_country] => US [patent_app_date] => 2004-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 25985 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20060275330.pdf [firstpage_image] =>[orig_patent_app_number] => 10553661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4463061 [patent_doc_number] => 07935346 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-03 [patent_title] => 'Medicament for the two-step perioperative therapy of solid tumours' [patent_app_type] => utility [patent_app_number] => 10/554410 [patent_app_country] => US [patent_app_date] => 2004-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2932 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/935/07935346.pdf [firstpage_image] =>[orig_patent_app_number] => 10554410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5850617 [patent_doc_number] => 20060233808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Peptabody for cancer treatment' [patent_app_type] => utility [patent_app_number] => 10/551977 [patent_app_country] => US [patent_app_date] => 2004-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 16127 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20060233808.pdf [firstpage_image] =>[orig_patent_app_number] => 10551977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5141340 [patent_doc_number] => 20070003556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Modified antibodies against cd22 and utilization thereof' [patent_app_type] => utility [patent_app_number] => 10/550934 [patent_app_country] => US [patent_app_date] => 2004-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8048 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20070003556.pdf [firstpage_image] =>[orig_patent_app_number] => 10550934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4497502 [patent_doc_number] => 07947812 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-24 [patent_title] => 'Neoplasm specific antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/549052 [patent_app_country] => US [patent_app_date] => 2004-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 16720 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/947/07947812.pdf [firstpage_image] =>[orig_patent_app_number] => 10549052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 588722 [patent_doc_number] => 07435590 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-14 [patent_title] => 'Monoclonal antibody and hybridoma producing the same' [patent_app_type] => utility [patent_app_number] => 10/548591 [patent_app_country] => US [patent_app_date] => 2004-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5670 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/435/07435590.pdf [firstpage_image] =>[orig_patent_app_number] => 10548591 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4995085 [patent_doc_number] => 20070010430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Proteoglycan isolated from cartilaginous fish and process for producing the same' [patent_app_type] => utility [patent_app_number] => 10/574400 [patent_app_country] => US [patent_app_date] => 2004-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9496 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20070010430.pdf [firstpage_image] =>[orig_patent_app_number] => 10574400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5595776 [patent_doc_number] => 20060159692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Transcriptional factor inducing apoptosis in cancer cell' [patent_app_type] => utility [patent_app_number] => 10/546829 [patent_app_country] => US [patent_app_date] => 2004-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 2889 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20060159692.pdf [firstpage_image] =>[orig_patent_app_number] => 10546829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5851046 [patent_doc_number] => 20060234237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators' [patent_app_type] => utility [patent_app_number] => 10/541749 [patent_app_country] => US [patent_app_date] => 2004-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 23775 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20060234237.pdf [firstpage_image] =>[orig_patent_app_number] => 10541749 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7082679 [patent_doc_number] => 20050048059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Therapeutic binding agents against MUC-1 antigen and methods for their use' [patent_app_type] => utility [patent_app_number] => 10/754089 [patent_app_country] => US [patent_app_date] => 2004-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10628 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20050048059.pdf [firstpage_image] =>[orig_patent_app_number] => 10754089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4515857 [patent_doc_number] => 07910711 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-22 [patent_title] => 'Human cancer-relating genes, the products encoded thereby and applications thereof' [patent_app_type] => utility [patent_app_number] => 10/540539 [patent_app_country] => US [patent_app_date] => 2003-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 26 [patent_no_of_words] => 9449 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/910/07910711.pdf [firstpage_image] =>[orig_patent_app_number] => 10540539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5732276 [patent_doc_number] => 20060257393 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Method for protecting thiol group of protein' [patent_app_type] => utility [patent_app_number] => 10/539756 [patent_app_country] => US [patent_app_date] => 2003-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7797 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20060257393.pdf [firstpage_image] =>[orig_patent_app_number] => 10539756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4629380 [patent_doc_number] => 08008266 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-30 [patent_title] => 'Methods of treating cancer using immunostimulatory oligonucleotides' [patent_app_type] => utility [patent_app_number] => 10/719493 [patent_app_country] => US [patent_app_date] => 2003-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 26780 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/008/08008266.pdf [firstpage_image] =>[orig_patent_app_number] => 10719493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 33138 [patent_doc_number] => 07790866 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-07 [patent_title] => 'Cancer-associated gene' [patent_app_type] => utility [patent_app_number] => 10/535733 [patent_app_country] => US [patent_app_date] => 2003-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17095 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/790/07790866.pdf [firstpage_image] =>[orig_patent_app_number] => 10535733 [rel_patent_id] =>[rel_patent_doc_number] =>)